Florida’s surgeon general has accused the Biden administration of “actively preventing” the distribution of monoclonal antibody treatments for COVID-19, causing an “immediate and life-threatening shortage of treatment options.”

In a letter to Health and Human Services Secretary Xavier Becerra on Tuesday, Dr. Joseph Ladapo alleged that HHS had reduced the number of antibodies allocated to the Sunshine State earlier this year “without any advanced notice.” //

​Another monoclonal antibody, GlaxoSmithKline’s Sotrovimab, appears to be more effective against Omicron and continues to be distributed by the federal government. ​But according to Ladapo, none has been allocated from the federal government to Florida, forcing the DeSantis administration to purchase a supply on its own.